This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.
Read the original research
Anti-GPC3 antibody and cell-penetrating peptide CPP44 dual-ligand modified liposomes for targeted delivery of arsenic trioxide in the treatment of hepatocellular carcinoma.
Journal of drug targeting, 33(6), 1004-1013
Citation
Lin, Congcong; Sun, Jiamin; Yang, Yun; Pan, Xinyao; Sun, Yifan; Sun, Bin; Gan, Chunli. (2025). Anti-GPC3 antibody and cell-penetrating peptide CPP44 dual-ligand modified liposomes for targeted delivery of arsenic trioxide in the treatment of hepatocellular carcinoma.. Journal of drug targeting, 33(6), 1004-1013. https://doi.org/10.1080/1061186X.2025.2461104